Skip to main content
Erschienen in: Neurological Sciences 6/2020

23.01.2020 | Original Article

Association between serum bilirubin and asymptomatic intracranial atherosclerosis: results from a population-based study

verfasst von: Kaiyi Zhong, Xiang Wang, Xiaotong Ma, Xiaokang Ji, Shaowei Sang, Sai Shao, Yuanyuan Zhao, Yuanyuan Xiang, Jifeng Li, Guangbin Wang, Ming Lv, Fuzhong Xue, Yifeng Du, Qinjian Sun

Erschienen in: Neurological Sciences | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The effects of bilirubin on asymptomatic intracranial atherosclerosis (aICAS) remain uncertain.

Objectives

To investigate the association between bilirubin and aICAS in rural-dwelling Chinese people.

Methods

This population-based study included 2013 participants from the Kongcun Town Study, which aimed to investigate the prevalence of aICAS in people aged ≥ 40 years who were free of stroke and hepatic and gall disease history. Baseline data were collected via interviews, clinical examinations, and laboratory tests. Total bilirubin (Tbil), direct bilirubin (Dbil), and indirect bilirubin (Ibil) levels were divided into high-concentration group and low-concentration group, respectively. We diagnosed aICAS and moderate-to-severe aICAS (m-saICAS) (≥ 50% stenosis) by integrating transcranial Doppler ultrasound with magnetic resonance angiography. The association between bilirubin and aICAS, as well as m-saICAS, was analyzed using logistic regression.

Results

Of the 2013 participants, those in the high-concentration group of Tbil (odds ratio (OR), 0.50; 95% confidence interval (CI), 0.42–0.87), Dbil (OR 0.60, 95%CI 0.41–0.87), and Ibil (OR 0.67; 95%CI 0.47–0.97) had a lower risk of aICAS than those in the low-concentration group after adjusting all confounders. The high concentrations of Tbil, Dbil, and Ibil were also negatively associated with m-saICAS. After stratification according to age, Tbil, Dbil, and Ibil were significantly negatively associated with aICAS among participants aged ≥ 60 years.

Conclusion

Tbil, Dbil, and Ibil might be independent protective factors for aICAS and moderate-to-severe aICAS in rural-dwelling Chinese people, especially among older participants aged ≥ 60 years.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Baracchini C, Anzola GP, Cenciarelli S, Diomedi M, Bella R, Tonon A, Braga M, Zedde ML, Zanferrari C, Del Sette M, Caliandro P, Gandolfo C, Ricci S, Meneghetti G (2016) Italian symptomatic intracranial atherosclerosis study (ISIDE) : a multicenter transcranial ultrasound evaluation. Neurol Sci 37(10):1645–1651. https://doi.org/10.1007/s10072-016-2642-6 CrossRefPubMed Baracchini C, Anzola GP, Cenciarelli S, Diomedi M, Bella R, Tonon A, Braga M, Zedde ML, Zanferrari C, Del Sette M, Caliandro P, Gandolfo C, Ricci S, Meneghetti G (2016) Italian symptomatic intracranial atherosclerosis study (ISIDE) : a multicenter transcranial ultrasound evaluation. Neurol Sci 37(10):1645–1651. https://​doi.​org/​10.​1007/​s10072-016-2642-6 CrossRefPubMed
14.
Zurück zum Zitat Jian Y, Zhao L, Wang H, Li T, Zhang L, Sun M, Dang M, Li Y, Zhang Y, Liu J, Sun H, Wang H, Zhang R, Jia Y, Zhang H, Zhang G (2019) Bilirubin: a novel predictor of hemorrhagic transformation and symptomatic intracranial hemorrhage after mechanical thrombectomy. Neurol Sci:1–7. https://doi.org/10.1007/s10072-019-04182-x Jian Y, Zhao L, Wang H, Li T, Zhang L, Sun M, Dang M, Li Y, Zhang Y, Liu J, Sun H, Wang H, Zhang R, Jia Y, Zhang H, Zhang G (2019) Bilirubin: a novel predictor of hemorrhagic transformation and symptomatic intracranial hemorrhage after mechanical thrombectomy. Neurol Sci:1–7. https://​doi.​org/​10.​1007/​s10072-019-04182-x
19.
Zurück zum Zitat Schwertner HA, Jackson WG, Tolan G (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40(1):18–23CrossRef Schwertner HA, Jackson WG, Tolan G (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40(1):18–23CrossRef
21.
Zurück zum Zitat Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Li JK, So WY, Cockram CS (1996) Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 3(5):459–463CrossRef Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Li JK, So WY, Cockram CS (1996) Serum bilirubin and cardiovascular risk factors in a Chinese population. J Cardiovasc Risk 3(5):459–463CrossRef
24.
Zurück zum Zitat Sun Q, Wang Q, Wang X, Ji X, Sang S, Shao S, Zhao Y, Xiang Y, Xue Y, Li J, Wang G, Lv M, Xue F, Qiu C, Du Y (2019) Prevalence and cardiovascular risk factors of asymptomatic intracranial arterial stenosis: the Kongcun Town Study in Shandong, China. Eur J Neurol. https://doi.org/10.1111/ene.14144 Sun Q, Wang Q, Wang X, Ji X, Sang S, Shao S, Zhao Y, Xiang Y, Xue Y, Li J, Wang G, Lv M, Xue F, Qiu C, Du Y (2019) Prevalence and cardiovascular risk factors of asymptomatic intracranial arterial stenosis: the Kongcun Town Study in Shandong, China. Eur J Neurol. https://​doi.​org/​10.​1111/​ene.​14144
25.
Zurück zum Zitat Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M, Stroke O, Neuroimaging of Intracranial Atherosclerosis Trial I (2007) The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 68(24):2099–2106. https://doi.org/10.1212/01.wnl.0000261488.05906.c1 CrossRefPubMed Feldmann E, Wilterdink JL, Kosinski A, Lynn M, Chimowitz MI, Sarafin J, Smith HH, Nichols F, Rogg J, Cloft HJ, Wechsler L, Saver J, Levine SR, Tegeler C, Adams R, Sloan M, Stroke O, Neuroimaging of Intracranial Atherosclerosis Trial I (2007) The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 68(24):2099–2106. https://​doi.​org/​10.​1212/​01.​wnl.​0000261488.​05906.​c1 CrossRefPubMed
26.
Zurück zum Zitat Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, Knorr M, Karbach S, Schuhmacher S, Wenzel P, Munzel T, Daiber A (2010) Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 49(2):186–195. https://doi.org/10.1016/j.yjmcc.2010.04.011 CrossRefPubMed Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, Knorr M, Karbach S, Schuhmacher S, Wenzel P, Munzel T, Daiber A (2010) Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 49(2):186–195. https://​doi.​org/​10.​1016/​j.​yjmcc.​2010.​04.​011 CrossRefPubMed
29.
35.
Zurück zum Zitat Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, Bulmer AC, Wagner KH (2013) Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) 125(5):257–264. https://doi.org/10.1042/CS20120661 CrossRef Wallner M, Marculescu R, Doberer D, Wolzt M, Wagner O, Vitek L, Bulmer AC, Wagner KH (2013) Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome. Clin Sci (Lond) 125(5):257–264. https://​doi.​org/​10.​1042/​CS20120661 CrossRef
Metadaten
Titel
Association between serum bilirubin and asymptomatic intracranial atherosclerosis: results from a population-based study
verfasst von
Kaiyi Zhong
Xiang Wang
Xiaotong Ma
Xiaokang Ji
Shaowei Sang
Sai Shao
Yuanyuan Zhao
Yuanyuan Xiang
Jifeng Li
Guangbin Wang
Ming Lv
Fuzhong Xue
Yifeng Du
Qinjian Sun
Publikationsdatum
23.01.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 6/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04268-x

Weitere Artikel der Ausgabe 6/2020

Neurological Sciences 6/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.